Results 11 to 20 of about 3,513,300 (309)
British Medical Bulletin, 2008 Gastric cancer remains a major cause of mortality and morbidity worldwide, and the total number of gastric cancer cases is predicted to rise as a result of population growth. The pathogenesis of gastric cancer represents a paradigm for microbially induced and inflammation-driven malignancies, and understanding this will be the best means of defeating ...
Paul, Lochhead, Emad M, El-Omar
openaire +2 more sources
BMC Surgery, 2020 Background The surgical Apgar score (SAS) or modified SAS (mSAS) has been reported as a simple and easy risk assessment system for predicting postoperative complications in primary surgery for gastric cancer. However, few studies have described the SAS’s
Masato Hayashi +7 more
doaj +1 more source
Surgical Case Reports, 2020 Background Laparoscopic gastrectomy is regarded a standard treatment procedure for early gastric cancer and is widely used in clinical practice. However, the feasibility of laparoscopic gastrectomy for patients with a prior history of open surgery ...
Ko Ikegame +5 more
doaj +1 more source
Annals of Gastroenterological Surgery, 2021 Aim Pancreas compression during minimally invasive gastrectomy causes blunt injury to the pancreas and leads to postoperative complications. However, the extent of practical compression associated with the incidence of postoperative complications remains
Kota Itamoto +6 more
doaj +1 more source
Amputation neuroma mimicking lymph node metastasis of remnant gastric cancer: a case report
Surgical Case Reports, 2017 Background Amputation neuromas (ANs) are reactive hyperplasia of nerve tissues that occur after a trauma or surgery involving the peripheral nerves. Only two previous reports of ANs occurring around the stomach and post gastrectomy have been reported. We
Kenichiro Furukawa +13 more
doaj +1 more source
BMC Cancer, 2021 Background Gastric outlet obstruction (GOO) is a late complication of advanced gastric cancer, and it is controversial how to select the therapeutic strategies: gastrojejunostomy and palliative gastrectomy?
Xiao-Jiang Chen +8 more
doaj +1 more source
Molecular diagnosis for personalized target therapy in gastric cancer [PDF]
, 2013 Gastric cancer is the second leading cause of cancer-related deaths worldwide. In advanced and metastatic gastric cancer, the conventional chemotherapy with limited efficacy shows an overall survival period of about 10 months.
조재용
core +1 more source
Long-Term Survival Outcomes of Elderly Patients Treated With S-1 or Capecitabine Plus Oxaliplatin for Stage II or III Gastric Cancer: A Multicenter Cohort Study [PDF]
, 2022 Purpose: Tegafur/gimeracil/oteracil (S-1) and capecitabine plus oxaliplatin (CAPOX) are standard adjuvant chemotherapies (ACs) administered after gastrectomy to patients with stage II or III gastric cancer. However, the efficacy of AC in elderly patients
김형일
core +1 more source
Prognostic value of tumoral expression of galectin-9 in gastric cancer
The Turkish Journal of Gastroenterology, 2017 Background/Aims: Galectin-9 (Gal-9) is a member of the β-galactoside-binding lectin family. Our previous study revealed that Gal-9 suppresses migration, invasion, and epithelial-mesenchymal transition in gastric cancer cells.
Sang Il Choi +5 more
doaj +1 more source
Laparoscopic resection of a primary diaphragmatic schwannoma: a case report and literature review
BMC Surgery, 2020 Background Schwannomas are nerve sheath tumors that commonly originate from the stomach and small intestine. A primary schwannoma of the diaphragm is rare and does not show any symptoms until it grows to a certain size.
Ayako Kamiya +8 more
doaj +1 more source